1)  ERCC1
ERCC1
1.
The prognostic impact of ERCC1 mRNA expression and polymorphism on gastric cancer patients treated with adjuvant chemotherapy;
ERCC1 mRNA表达及基因多态性对胃癌辅助化疗预后的影响
2.
Expression of sFas in serum,Survivin and ERCC1 in tissue correlate with effect of paclitaxol plus cisplatin in lung adenocarcinoma cancer;
血清sFas,组织Survivin、ERCC1同肺腺癌TP方案疗效相关性
3.
ERCC1 protein expression in relation to chemotherapy sensitivity of stage Ⅲ/Ⅳ NSCLC patients treated with cisplatin-based chemotherapy;
非小细胞肺癌患者ERCC1蛋白表达与铂类标准方案化疗敏感性的关系研究
2)  ERCC1
切除修复交叉互补集团1基因（ERCC1）
3)  ERCC1
核苷酸切除修复交叉互补基因-1
1.
Expression of ERCC1 in colorectal cancer and its clinical significance;
核苷酸切除修复交叉互补基因-1在结直肠癌中的表达及其意义
4)  ERCC1
切除修复交叉互补基因
5)  ERCC1
交叉互补集团1基因
1.
Objective To elucidate the effect of ERCC1 on Oxaliplatin cytotoxicity and finding the key element related to Oxaliplatin anti-tumor resistance.
目的探讨交叉互补集团1基因(ERCC1)蛋白在草酸铂毒性作用的影响,找寻草酸铂药物抵抗性的关键因子。
6)  ERCC1 gene
ERCC1基因
1.
Effect of neoadjuvant chemotherapy on ERCC1 gene expression in breast cancer;
乳腺癌新辅助化疗对ERCC1基因表达的影响
2.
The aim of this study is to investigate the influence of low-dose cisplatin on expression of ERCC1 gene and to confirm the correlation between ERCC1 and cisplatin resistance in human lung adenocarcinoma cell lines.
浓度为5μmol/L的DDP即可刺激A549细胞中ERCC1基因水平上升,而随着DDP浓度的增加,ERCC1 mRNA水平逐渐上升,20μmol/L组达高峰(79。
3.
Objective:To study the effect on drug resistance by RNAi mediated ERCC1 gene silencing in ovarian cancer cell line.
目的:观察RNA干扰沉默ERCC1基因对卵巢癌细胞耐药的影响。
参考词条
补充资料：基因内互补


基因内互补
intragenic complementation

　　指带有处于反式(即相斥）状态的两个拟等位基因的个体呈现接近正常表型的现象。可能是由于两个突变基因所产生的失活产物结合而成为具有活性的蛋白质的结果。如果将两个有关的同质结合子的抽提物混合时可以看到互补现象，叫离体互补。
　　
说明：补充资料仅用于学习参考，请勿用于其它任何用途。